CHIEF MEDICAL OFFICERCIK 0001902368
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Inrig JulaEVP, Head of R&D & CMO |  TVTXTravere Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $1.08M 17.3K sh | Sep 17, 2026 traded Sep 15, 2026 | |
Inrig JulaEVP, Head of R&D & CMO |
| TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan |
| SELL |
| $102K 1,600 sh |
| Sep 17, 2026 traded Sep 15, 2026 |
| 6 | Inrig JulaEVP, Head of R&D & CMO | TVTXTravere Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $289K 32.4K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 8 | Inrig JulaEVP, Head of R&D & CMO | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $26K 400 sh | Sep 17, 2026 traded Sep 15, 2026 |
| 4 | Inrig JulaEVP, Head of R&D & CMO | TVTXTravere Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 32.4K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 21 | Inrig JulaEVP, Head of R&D & CMO | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $1.57M 25.4K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 5 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Gift | G | — 468 sh | Jun 22, 2026 traded Jun 22, 2026 |
| 0 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 4,250 sh | May 6, 2026 traded May 4, 2026 |
| 2 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $448K 20.0K sh | May 6, 2026 traded May 4, 2026 |
| 0 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 4,250 sh | May 6, 2026 traded May 4, 2026 |
| 23 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $900K 20.0K sh | May 6, 2026 traded May 4, 2026 |
| 16 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $101K 2,174 sh | May 6, 2026 traded May 5, 2026 |
| 13 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $14K 311 sh | May 6, 2026 traded May 6, 2026 |
| 0 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Grant or award · 10b5-1 plan | A | — 8,500 sh | May 6, 2026 traded May 4, 2026 |
| 4 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 20.0K sh | May 6, 2026 traded May 4, 2026 |
| 13 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $43K 1,018 sh | Apr 15, 2026 traded Apr 15, 2026 |
| 0 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Grant or award · 10b5-1 plan | A | — 14.0K sh | Apr 15, 2026 traded Apr 13, 2026 |
| 26 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $303K 7,215 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 11 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $7,621 232 sh | Feb 5, 2026 traded Feb 4, 2026 |
| 11 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $50K 1,547 sh | Feb 5, 2026 traded Feb 4, 2026 |
| 19 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $82K 2,031 sh | Jan 7, 2026 traded Jan 5, 2026 |
| 16 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $17K 445 sh | Jan 7, 2026 traded Jan 6, 2026 |
| 12 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $134K 15.0K sh | Dec 29, 2025 traded Dec 24, 2025 |
| 36 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $630K 15.0K sh | Dec 29, 2025 traded Dec 24, 2025 |
| 13 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 15.0K sh | Dec 29, 2025 traded Dec 24, 2025 |